A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.

Autor: O'Donnell MR; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; Department of Epidemiology, and.; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA., Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Cummings MJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA., Justman JE; Department of Epidemiology, and.; ICAP, Columbia University Mailman School of Public Health, New York, New York, USA.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Lamb MR; Department of Epidemiology, and.; ICAP, Columbia University Mailman School of Public Health, New York, New York, USA., Eckhardt CM; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Philip NM; ICAP, Columbia University Mailman School of Public Health, New York, New York, USA., Cheung YK; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York, USA., Gupta V; Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA., João E; Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Pilotto JH; Hospital Geral de Nova Iguaçu, Rio de Janeiro, Brazil and Laboratório de Aids e Imunologia Molecular, Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Brazil., Diniz MP; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Cardoso SW; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Abrams D; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Rajagopalan KN; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Borden SE; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Wolf A; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Sidi LC; Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Vizzoni A; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Veloso VG; Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil., Bitan ZC; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Scotto DE; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Meyer BJ; Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA., Jacobson SD; Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA., Kantor A; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Mishra N; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA., Chauhan LV; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA., Stone EF; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Dei Zotti F; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., La Carpia F; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Hudson KE; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Ferrara SA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Schwartz J; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Stotler BA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Lin WW; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Wontakal SN; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Shaz B; New York Blood Center, New York, New York, USA., Briese T; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA., Hod EA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Spitalnik SL; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Eisenberger A; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Lipkin WI; Department of Epidemiology, and.; Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, USA.; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2021 Jul 01; Vol. 131 (13).

High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.

Autor: de Lourdes Teixeira M; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil Laboratory of Epidemiology Research and Social Determinants of Health, Instituto Nacional de Infectologia Evandro Chagas INI/IPEC-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Nafea S; David Geffen School of Medicine at UCLA, Department of Pediatrics, Division of Infectious Diseases, University of California, Los Angeles, CA, USA., Yeganeh N; David Geffen School of Medicine at UCLA, Department of Pediatrics, Division of Infectious Diseases, University of California, Los Angeles, CA, USA., Santos E; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Gouvea MI; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil Laboratory of Epidemiology Research and Social Determinants of Health, Instituto Nacional de Infectologia Evandro Chagas INI/IPEC-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Joao E; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Ceci L; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Bressan C; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Cruz ML; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Sidi LC; Department of Infectious Diseases, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Nielsen-Saines K; David Geffen School of Medicine at UCLA, Department of Pediatrics, Division of Infectious Diseases, University of California, Los Angeles, CA, USA knielsen@mednet.ucla.edu.

Publikováno v: International journal of STD & AIDS [Int J STD AIDS] 2015 Nov; Vol. 26 (13), pp. 922-8. Date of Electronic Publication: 2014 Dec 09.

Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.

Autor: Joao EC; Department of Infectious Diseases, Hospital dos Servidores do Estado, Rio de Janeiro, Brazil. esau@uninet.com.br, Gouvêa MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, Ceci L, Cardoso CA, Teixeira Mde L, Calvet GA, Matos HJ

Publikováno v: International journal of STD & AIDS [Int J STD AIDS] 2012 Jan; Vol. 23 (1), pp. 44-7.

Successful desensitization of enfuvirtide after a first attempt failure.

Autor: Machado ES, Passoni LF, Sidi LC, Andrade HB, De Menezes JA

Publikováno v: AIDS (London, England) [AIDS] 2006 Oct 24; Vol. 20 (16), pp. 2130-1.

The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission.

Autor: Yang, Lanbo, Cambou, Mary Catherine, Nielsen-Saines, Karin

Publikováno v: Current HIV/AIDS Reports; Jun2023, Vol. 20 Issue 3, p121-130, 10p